Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378348346> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4378348346 endingPage "1519" @default.
- W4378348346 startingPage "1516" @default.
- W4378348346 abstract "Introduction Acute toxic leukoencephalopathy (ATL) is a rare complication of cancer treatment, with symptoms varying from mild cognitive impairment to coma. Recognition and management of ATL are important because in most cases, the cessation of the responsible agent is essential. Case report We report a case of a 57-year-old male with relapsed right colon cancer who had multiple steps of chemotherapy, admitted to the emergency department (ED) with confusion and inability to talk, 4 days after FOLFIRI and bevacizumab treatment. To exclude cerebrovascular events cranial computed tomography and diffusion-weighted magnetic resonance imaging were evaluated. There was bilateral and symmetric diffusion restriction on white matter, which was consistent with ATL. Management and outcome Supportive treatment such as optimization of blood pressure and metabolic control was applied since there is no specific treatment for ATL other than cessation of the responsible agents. 12 days after the admission to the ED his neurologic symptoms were normalized and there was no diffusion restriction on control imaging. Discussion ATL is a rare complication of cancer treatment and responsible agents are increasing in number due to the development of cancer treatment. ATL is associated with drugs that are used frequently such as 5-fluorouracil. ATL is mostly reversible, but the progression of neurologic symptoms was also reported. The diagnosis and cessation of the responsible agent are important in management." @default.
- W4378348346 created "2023-05-27" @default.
- W4378348346 creator A5019105829 @default.
- W4378348346 creator A5028181587 @default.
- W4378348346 creator A5060898829 @default.
- W4378348346 creator A5079931964 @default.
- W4378348346 date "2023-05-25" @default.
- W4378348346 modified "2023-10-14" @default.
- W4378348346 title "FOLFIRI-bevacizumab-induced acute toxic leukoencephalopathy" @default.
- W4378348346 cites W2093341095 @default.
- W4378348346 cites W2605915516 @default.
- W4378348346 cites W2908605138 @default.
- W4378348346 cites W2914609506 @default.
- W4378348346 cites W3197667885 @default.
- W4378348346 cites W4281290727 @default.
- W4378348346 cites W4289544694 @default.
- W4378348346 doi "https://doi.org/10.1177/10781552231178680" @default.
- W4378348346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37231633" @default.
- W4378348346 hasPublicationYear "2023" @default.
- W4378348346 type Work @default.
- W4378348346 citedByCount "1" @default.
- W4378348346 countsByYear W43783483462023 @default.
- W4378348346 crossrefType "journal-article" @default.
- W4378348346 hasAuthorship W4378348346A5019105829 @default.
- W4378348346 hasAuthorship W4378348346A5028181587 @default.
- W4378348346 hasAuthorship W4378348346A5060898829 @default.
- W4378348346 hasAuthorship W4378348346A5079931964 @default.
- W4378348346 hasConcept C100136789 @default.
- W4378348346 hasConcept C118552586 @default.
- W4378348346 hasConcept C120665830 @default.
- W4378348346 hasConcept C121332964 @default.
- W4378348346 hasConcept C121608353 @default.
- W4378348346 hasConcept C126322002 @default.
- W4378348346 hasConcept C126838900 @default.
- W4378348346 hasConcept C141071460 @default.
- W4378348346 hasConcept C143409427 @default.
- W4378348346 hasConcept C187212893 @default.
- W4378348346 hasConcept C2776694085 @default.
- W4378348346 hasConcept C2776705615 @default.
- W4378348346 hasConcept C2777802072 @default.
- W4378348346 hasConcept C2778583010 @default.
- W4378348346 hasConcept C2780259306 @default.
- W4378348346 hasConcept C2780724011 @default.
- W4378348346 hasConcept C526805850 @default.
- W4378348346 hasConcept C71924100 @default.
- W4378348346 hasConcept C81182388 @default.
- W4378348346 hasConceptScore W4378348346C100136789 @default.
- W4378348346 hasConceptScore W4378348346C118552586 @default.
- W4378348346 hasConceptScore W4378348346C120665830 @default.
- W4378348346 hasConceptScore W4378348346C121332964 @default.
- W4378348346 hasConceptScore W4378348346C121608353 @default.
- W4378348346 hasConceptScore W4378348346C126322002 @default.
- W4378348346 hasConceptScore W4378348346C126838900 @default.
- W4378348346 hasConceptScore W4378348346C141071460 @default.
- W4378348346 hasConceptScore W4378348346C143409427 @default.
- W4378348346 hasConceptScore W4378348346C187212893 @default.
- W4378348346 hasConceptScore W4378348346C2776694085 @default.
- W4378348346 hasConceptScore W4378348346C2776705615 @default.
- W4378348346 hasConceptScore W4378348346C2777802072 @default.
- W4378348346 hasConceptScore W4378348346C2778583010 @default.
- W4378348346 hasConceptScore W4378348346C2780259306 @default.
- W4378348346 hasConceptScore W4378348346C2780724011 @default.
- W4378348346 hasConceptScore W4378348346C526805850 @default.
- W4378348346 hasConceptScore W4378348346C71924100 @default.
- W4378348346 hasConceptScore W4378348346C81182388 @default.
- W4378348346 hasIssue "6" @default.
- W4378348346 hasLocation W43783483461 @default.
- W4378348346 hasLocation W43783483462 @default.
- W4378348346 hasOpenAccess W4378348346 @default.
- W4378348346 hasPrimaryLocation W43783483461 @default.
- W4378348346 hasRelatedWork W1557534319 @default.
- W4378348346 hasRelatedWork W1792988773 @default.
- W4378348346 hasRelatedWork W2007060363 @default.
- W4378348346 hasRelatedWork W2029464197 @default.
- W4378348346 hasRelatedWork W2416369235 @default.
- W4378348346 hasRelatedWork W2590977625 @default.
- W4378348346 hasRelatedWork W2601923086 @default.
- W4378348346 hasRelatedWork W2610384061 @default.
- W4378348346 hasRelatedWork W2732470776 @default.
- W4378348346 hasRelatedWork W2947476279 @default.
- W4378348346 hasVolume "29" @default.
- W4378348346 isParatext "false" @default.
- W4378348346 isRetracted "false" @default.
- W4378348346 workType "article" @default.